TeraImmune
Germantown, US · Founded 2019
Biotech
Founders & leadership
JP
Jihoon ParkExecutive Officer, Director
YC
Yong Chan Kim, PhDExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$3MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jihoon ParkExecutive Officer, Director
- Yong Chan Kim, PhDExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.